PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Corporate Responsibility
Genentech Runs Voluntary Corrective Ads for Boniva
Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Also posted in Advertising, FDA, Legal, Marketing, Regulatory, compliance, leadership Tagged DDMAC, Genentech, OPDP, Roche Leave a comment
Tiered Pricing Not Always a Win-Win
Tiered pricing, or selling critical medicines to developing countries at a standardized discount price, can improve access in the short term, but arbitrary demographic groupings and misaligned incentives often stack the deck in favor of manufacturers, not patients.
Also posted in Emerging Markets, Global, IP, Manufacturing, Market Access, R&D, Strategy, pricing 2 Comments
What Pharma Could Do for Occupy Wall Street
Demonstrators at Zuccotti Park in New York City persevered through the first snow of the season, while reports from other U.S.-based occupations – in Denver, Oakland, Nashville and other cities – are tallying the arrests, which have become increasingly frequent, and forceful. “The whole world is watching,” a chant that gained prominence during anti-war protests [...]
Also posted in Events, Market Access, Strategy, leadership Tagged Occupy Wall Street, OWS 7 Comments
New Coalition Takes on Neglected Tropical Diseases
A new coalition for sharing pharma IP takes aim at the increasing burden of neglected tropical diseases in the developing world.
According to the World Health Organization, neglected tropical diseases affect more than one billion of the world’s poorest 2.7 billion people. Many of these diseases, which can cause blindness and other debilitating symptoms, have reached [...]
Also posted in IP Tagged BIO Ventures for Global Health, NIH, Research, tropical diseases, WHO, WIPO Leave a comment
Supreme Court Considers the Affordable Care Act